期刊
JOURNAL OF MEDICAL GENETICS
卷 59, 期 2, 页码 204-208出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2020-107367
关键词
brain diseases; metabolic
This study investigates the relationship between PNPT1 gene and mitochondrial diseases, and describes the neuroimaging findings in 6 patients with PNPT1. The study identifies novel lesions and provides important clues for further understanding of this disease.
Background Biallelic variants in PNPT1 cause a mitochondrial disease of variable severity. PNPT1 (polynucleotide phosphorylase) is a mitochondrial protein involved in RNA processing where it has a dual role in the import of small RNAs into mitochondria and in preventing the formation and release of mitochondrial double-stranded RNA into the cytoplasm. This, in turn, prevents the activation of type I interferon response. Detailed neuroimaging findings in PNPT1-related disease are lacking with only a few patients reported with basal ganglia lesions (Leigh syndrome) or non-specific signs. Objective and methods To document neuroimaging data in six patients with PNPT1 highlighting novel findings. Results Two patients exhibited striatal lesions compatible with Leigh syndrome; one patient exhibited leukoencephalopathy and one patient had a normal brain MRI. Interestingly, two unrelated patients exhibited cystic leukoencephalopathy resembling RNASET2-deficient patients, patients with Aicardi-Goutieres syndrome (AGS) or congenital CMV infection. Conclusion We suggest that similar to RNASET2, PNPT1 be searched for in the setting of cystic leukoencephalopathy. These findings are in line with activation of type I interferon response observed in AGS, PNPT1 and RNASET2 deficiencies, suggesting a common pathophysiological pathway and linking mitochondrial diseases, interferonopathies and immune dysregulations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据